Advancing Healthcare Webinar SeriesClinical education series on topics affecting healthcare professionals, including COVID-19

Lab Week 2021

In honor of Lab Week, Siemens Healthineers recognizes the behind-the-scenes heroes who work hard every day to make sure test results are delivered quickly and accurately. We created this short video tribute to express our appreciation for everything you do. Thank you!

Scientific and clinical experts from Siemens Healthineers, as well as other industry leaders in laboratory diagnostics, will provide information and answer questions on trends and developments important to healthcare professionals. These timely discussions are available live or on-demand for your convenience. Questions can be submitted in either format, and a Siemens Healthineers representative will respond promptly.

Managing Sepsis with Procalcitonin

Learn more about the challenges healthcare providers face treating patients with sepsis - particularly those with COVID-19. Data will be presented, and questions answered on the Atellica IM BRAHMS Procalcitonin assay.

After this webinar, participants will:

  • Understand the definition of sepsis
  • Identify the common biomarkers of sepsis
  • Examine the clinical utility of an Atellica IM BRAHMS Procalcitonin assay

Speaker:
Monet Sayegh, MD, MHSc, BS, MT(ASCP)SH, CLS
Senior Clinical Consultant, Disease State Education
Siemens Healthineers

Dr. Sayegh has over 30 years of experience in the fields of medicine, research, abdominal laparoscopic surgery and clinical laboratory science. His background includes extensive research in immunology/allergy, hematology/oncology, endocrinology, special chemistry, HLA histocompatiblity and maternal screen. He is a senior clinical consultant and a member of the Disease State Education group at Siemens Healthineers, focusing on cardiovascular, oncology, and infectious diseases.

Available: October 7, 2020


COVID-19 and Cytokine Storm

Cytokine storm syndrome is associated with severe COVID-19 disease, caused by a dysregulated immune response to infection. Data on how IL-6 is thought to be the central regulator of the cytokine response and cytokine storm will be discussed.

After this webinar, participants will:

  • Identify the implications of cytokine storm in severe COVID-19 disease.
  • Recognize IL-6 as the central regulator of the cytokine response and cytokine storm.
  • Describe the association of elevated IL-6 levels with higher risk of progressing to sever disease or death in COVID-19 patients.

Speaker:
Dr. John Mitsios, Ph.D.

Clinical Consultant, Siemens Healthineers

Dr. Mitsios is a clinical consultant in the Scientific and Clinical Affairs team at Siemens Healthineers. His primary research interest throughout his education and training has been in coagulation, with an emphasis on platelet function and biology. Dr. Mitsios was on the faculty at Weill Cornell University as an Assistant professor of Pathology and Laboratory Medicine, as well as Assistant Attending Clinical Chemist at New York-Presbyterian Hospital. He was Assistant Director of the Special Coagulation Laboratory at BioReference Laboratories, overseeing the day-to-day activities of the lab and signing out clinical hemostasis cases.


The Clinical Utility of High Sensitivity Troponin

High sensitivity troponin allows for the use of accelerated diagnostic protocols, which can shorten the time to rule out patients suspected of an MI. Understand how this assay has dramatically improved precision at the medical decision level.

After this webinar, participants will:

  • Describe the difference between contemporary and high sensitivity troponin assays
  • Describe the use of high sensitivity troponin for the early diagnosis of MI
  • Discuss using various options for the implementation of high sensitivity troponin

Speaker:
Dr. Jim Aguanno, Ph.D.
Senior Clinical Consultant, Siemens Healthineers.

Dr. Jim Aguanno has over 40 years of experience in laboratory medicine. He received a Bachelor of Science in Chemistry and a Ph.D. in Biochemistry from Memphis State University. Following his Ph.D., he did two post-doctoral fellowships one at the University of Pittsburgh School of Medicine in Biochemistry and a second fellowship in Laboratory Medicine at Washington University School of Medicine and Barnes Hospital in St. Louis, Missouri. Dr. Aguanno was Director of the Core Laboratory at Baylor University Medical Center in Dallas, Texas for 24 years. Dr. Aguanno joined Siemens Healthcare Diagnostics in January of 2004 and is currently Senior Clinical Consultant in the Clinical and Scientific Affairs group focusing on cardiovascular disease, infectious diseases and general aspects of laboratory medicine.


The impact of PCR and Serology Testing on overcoming COVID-19

SARS-CoV-2 has had a profound effect on patients with severe disease. COVID-19 can affect many organ systems including lungs, heart, kidneys, liver, brain, and others. The diagnosis of patients suspected of COVID-19 relies upon clinical presentation as well as laboratory findings. Polymerase chain reaction (PCR) remains the primary diagnostic tool to confirm the presence of the virus. However, SARS-CoV-2 antibody testing also plays an important role in the determination of a patient’s immune response to the virus.

After this webinar, participants will:

  • Better understand the various types of diagnostic tests for SARS-CoV-2 infection
  • Recognize some of the advantages and limitations of both PCR and antibody testing
  • Appreciate the impact of sensitivity and specificity of antibody testing on positive and negative predictive value

Speaker:
Dr. Jim Aguanno, Ph.D.

Senior Clinical Consultant, Siemens Healthineers.

Dr. Jim Aguanno has over 40 years of experience in laboratory medicine. He received his Bachelor of Science in Chemistry and a Ph.D. in Biochemistry from Memphis State University. Following his Ph.D., he did two post-doctoral fellowships one at the University of Pittsburgh School of Medicine in Biochemistry and a second fellowship in Laboratory Medicine at Washington University School of Medicine and Barnes Hospital in St. Louis, Missouri. Dr. Aguanno was Director of the Core Laboratory at Baylor University Medical Center in Dallas, Texas for 24 years. Dr. Aguanno joined Siemens Healthcare Diagnostics in January of 2004 and is currently Senior Clinical Consultant in the Clinical and Scientific Affairs group focusing on cardiovascular disease, infectious diseases and general aspects of laboratory medicine.


Discussion Reagents L1 RGB

Learn about patient variables, specimen collection, processing, and storage, as well as conditions and substances potentially interfering with testing of different coagulation parameters.

Dr. John Mitsios, PhD, our Senior Clinical Hemostasis Consultant at Siemens Healthineers will help you:

  • Identify proper coagulation patient sample collection and preparation
  • Define the effect of time and temperature on coagulation results
  • Describe preanalytical interferences associated with diagnostic errors
  • Explain the effect of HIL and fill volume on coagulation results

Speaker: Dr. Mitsios graduated from the University of Ioannina, Greece with a PhD in Chemistry. Upon completion of his doctoral thesis, he then went on to complete a post-doctoral fellowship at the University of California, San Diego under the mentorship of Dr. Sanford J. Shattil. Dr. Mitsios then transitioned to the world of Clinical Chemistry and completed a fellowship at Washington University in St. Louis, MO. His primary research interest throughout his education and training has been in coagulation, with an emphasis on platelet function and biology. Recently Dr. Mitsios joined Siemens-Healthineers as a clinical consultant as part of the Scientific and Clinical Affairs team. In addition, Dr. Mitsios has co-authored 20 peer-reviewed articles and 3 book chapters.


COVID-19 and Cardiovascular Complications<br />

Learn how infection from SARS-CoV-2 can lead to severe pulmonary complications in many patients. Although the clinical manifestations of COVID-19 are dominated by respiratory symptoms, some patients have severe cardiovascular damage. Cardiac troponin and more specifically high sensitivity troponin may play an important role in the identification the patients a greatest risk of severe complications.

After this webinar, participants will:

  • Discuss some of the cardiac complications seen in COVID-19 patients
  • Discuss some of the mechanisms causing myocardial injury in COVID-19 patients
  • Discuss the potential clinical utility of cardiac troponin as a prognostic marker in COVID-19 patients

Speaker:
Dr. Jim Aguanno, Ph.D.
Senior Clinical Consultant, Siemens Healthineers.

Dr. Jim Aguanno has over 40 years of experience in laboratory medicine. He received his Bachelor of Science in Chemistry and a Ph.D. in Biochemistry from Memphis State University. Following his Ph.D., he did two post-doctoral fellowships one at the University of Pittsburgh School of Medicine in Biochemistry and a second fellowship in Laboratory Medicine at Washington University School of Medicine and Barnes Hospital in St. Louis, Missouri. Dr. Aguanno was Director of the Core Laboratory at Baylor University Medical Center in Dallas, Texas for 24 years. Dr. Aguanno joined Siemens Healthcare Diagnostics in January of 2004 and is currently Senior Clinical Consultant in the Clinical and Scientific Affairs group focusing on cardiovascular disease, infectious diseases and general aspects of laboratory medicine.

Available: January 13, 2021


COVID-19

A clinical overview on SARS-CoV-2, including viral structure, route(s) of transmission, immune response, vaccines, and highly-circulating emergent variants. The clinical value of serology will be reviewed, including current guidance on the use of antibody testing as well as evolving applications. Distinctions in available serology assays specific to viral targets (nucleocapsid vs. spike-based assays) will be discussed relative to both natural infection and vaccination.

After this webinar, participants will:

  • Describe the structure of SARS-CoV-2, routes of transmission, and genetic variants
  • Understand the immune response to infection, and the importance of neutralizing antibodies
  • Understand the role of serology testing both in natural infection and following vaccination

Speaker:
Dr. Katherine Soreng, Ph.D.
Global Director of Clinical Education, Siemens Healthineers.

Dr. Soreng currently heads Global Clinical Education for Laboratory Diagnostics at Siemens Healthineers. She writes and educates on a variety of clinical diagnostic disease states, including Infectious Disease, Liver Fibrosis, and Cardiology. Dr. Soreng completed her BS in Biology at the University of Washington in Seattle and her PhD in Immunology and Molecular Pathogenesis at Emory University in Atlanta, GA. As an undergraduate, she conducted research on human herpes viruses, including clinical testing and diagnosis. She completed a 2-year post-doctoral fellowship at the Centers for Disease Control and Prevention in the National Centers for Infectious Disease, where she investigated pathogenic factors associated with measles virus infection.

Available: January 27, 2021


Laboratory Informatics Webinar

Learn how innovation in informatics (Lab Middleware) can provide a seamless workflow resulting in predictable test turnaround time for critical assays used for patients walking in the Emergency room. The webinar will also highlight best practices for a 24/7 hospital laboratory to introduce and customize the result management software (Lab middleware) and critical role of engaging laboratory technologist as agents of change.

Learning Objectives:

  • Best practices of innovation-based change management within a 24/7 multi-disciplinary core laboratory
  • How laboratory middleware enables a laboratory to meet their turnaround time needs
  • Engaging and empowering key laboratory stakeholders to lead the change
  • Learn how effective data management can help standardize operation while reducing stress in the laboratory

Speaker:
Susan Dawson
Laboratory Director, Swedish Hospital (Part of NorthShore)

Susan Dawson MBA, MT(ASCP) is the Lab Director of Swedish Hospital, part of the NorthShore University Health System serving the greater Chicago area. Susan oversees all laboratory operations at Swedish hospital and her career includes more than 30 year of experience managing patient testing with a strong focus on chemistry, immunochemistry, hematology, hemostasis, and microbiology testing. She is a constant adopter of innovation and has presented internationally on numerous occasions on the experience and best practices of laboratory automation and IT. Susan has an MBA with distinction from North Park University and a B.A., in Medical Technology from Augustana College.

Available: February 10th, 2021


Opioid Crisis Webinar

In this webinar, you will learn about the three waves of the opioid crisis, the epidemiological factors that influence it, the impact of the COVID-19 pandemic, and potential resolutions to tame the opioid crisis. You will also learn about the need for comprehensive opioid drug abuse testing with attention to specific drugs and drug classes: Oxycodone, Heroin, Fentanyl, Tramadol.

Speaking on these findings, Dr. Steven Noel, Ph.D., Senior Clinical Consultant at Siemens Healthineers, will help you …

  • Understand the current status of the opioid crisis and how it came to epidemic proportions, gaining an appreciation of the epidemiology of the crisis; that is, the impact of pain management, prescription drug dispensing, licit and illicit drug proliferation and COVID-19.
  • Discover the need for comprehensive drug testing, learning about opioid-related drug abuse testing.
  • Gain insight into encouraging approaches to tame the opioid crisis and improve public health outcomes.

Speaker:
Steven A. Noel, PhD (DABCC), MT (ASCP)
Senior Clinical Consultant, Siemens Healthineers.

Dr. Noel is a board-certified Clinical Chemist, receiving his doctorate from the Ohio State University. He has served in different capacities in laboratory medicine throughout his 40-year career. As a Clinical Chemist, Dr. Noel served as Technical Director in hospital and commercial laboratories. In addition, his career has led him to dual roles as Technical and Operations Director, and he recently served as the VP of Operations at a national toxicology laboratory. Dr. Noel has published on clinical laboratory assay topics in reproductive endocrinology, cholesterol metabolism and other disease states involving immunoassay testing.

Available: February 17th, 2021


ER Gurney

Join Siemens Healthineers and world-renowned cardiac expert Professor Dr. Fred Apple. Learn about the latest guidelines including the controversial 2020 European Society for Cardiology (ESC) NSTEMI guidelines and the NICE guidelines. Professor Apple will discuss why the 2020 ESC NSTEMI guidelines may be considered controversial and will share his hard-hitting interpretation perspectives and review of the evidence.

Speaking on these findings, Dr. Fred Apple, Ph.D. Medical Director of Clinical Laboratories at Hennepin County Medical Center, will help you:

  • Discuss the latest guidelines including the controversial 2020 ESC NSTEMI guidelines and the NICE guidelines
  • Understand why the 2020 ESC NSTEMI guidelines are controversial with hard-hitting interpretation perspectives from Prof. Apple including a biased reference compendium and misguided 99th percentile figure
  • Understand the early rule out and rule in strategies using high sensitivity cardiac troponin testing

Speaker:

Fred S. Apple, Ph.D., DABCC
Medical Director of Clinical Laboratories
Hennepin County Medical Center

Prof. Apple’s research interests have centered in the areas of cardiac biomarkers in acute coronary syndrome and heart failure. His CLIA-certified research laboratory is the “Cardiac Biomarker Trials Lab” at the Hennepin Healthcare Research Institute of Hennepin County Medical Center/Hennepin Healthcare. Prof. Apple is a Professor of Laboratory Medicine & Pathology at the University of Minnesota. He has served as an associate editor of Clinical Chemistry for the past 20 years. He also serves as a member of the global task force on the universal definition of myocardial infarction and myocardial injury, chair of the IFCC committee on clinical applications of cardiac biomarkers, member of the AACC Academy committee on laboratory medicine practice guidelines for myocardial infarction and heart failure, and member of the AACC Clinical Societies Collaboration Committee.


Doctors

In this webinar, you will learn about testing produces data for screening of patients and monitoring anticoagulant therapy in Coagulation testing. Performing assay validation, calibration, reference ranges, and new reagent lot verification present challenges to the laboratory. A robust quality assurance system provides peace of mind and confidence in patient results.

Speaking on these findings, a panel of technical experts to help you:

  • Define basic statistics and their use for Quality in the Coagulation Lab
  • Identify sources and utility of External Quality Assurance programs
  • Evaluate examples of Quality Statistics in Peer Comparison Programs
  • Utilize report flags and examples to guide troubleshooting as necessary
  • Provide guidance on annual lot rollover procedures and requirements
  • Summarize offerings of the Siemens Quality Assurance Program (QAP)

Speakers:

John V. Mitsios, Ph.D., Coagulation Clinical Consultant, Siemens Healthineers

Regina Provenza, MT(ASCP), Coagulation Application Specialist, Remote Services Center, Siemens Healthineers

Dana Ohnmeiss, MT (ASCP), CTT+ Coagulation Applications Specialist, Headquarters Support Center, Siemens Healthineers

Sandy Gardner, BS, MT(ASCP), Coagulation Marketing Manager, Siemens Healthineers


blue

In this webinar, learn how to effectively identify and treat patients with diabetes so laboratorians can be confident in their results. Gain insight into analytical and quality parameters that assure appropriate clinical decisions for identifying, classifying, monitoring patients with type I or II diabetes, gestational diabetes, and prediabetes.

Speaking on these findings, Dr. Steven A. Noel, Ph.D. senior clinical consultant at Siemens Healthineers, will help you:

  • Understand the epidemiological characteristics and impact of diabetes
  • Learn about the biochemistry and pathophysiological aspects of the disease.
  • Discover the clinical utility of hemoglobin A1c.
  • Gain insight into analytical and quality parameters that assure appropriate clinical decisions for identifying, classifying, monitoring patients with type I or II diabetes

Speaker:
Steven A. Noel, PhD (DABCC), MT (ASCP)
Senior Clinical Consultant
Siemens Healthineers

Dr. Noel is a board-certified Clinical Chemist, receiving his doctorate from the Ohio State University. He has served in different capacities in laboratory medicine throughout his 40-year career. As a Clinical Chemist, Dr. Noel served as Technical Director in hospital and commercial laboratories. In addition, his career has led him to dual roles as Technical and Operations Director, and he recently served as the VP of Operations at a national toxicology laboratory. Dr. Noel has published on clinical laboratory assay topics in reproductive endocrinology, cholesterol metabolism and other disease states involving immunoassay testing.


Lab professionals at computer

In this webinar, Jennifer will explain the role of Lab middleware in the Core Laboratory. The webinar will explain how lab middleware differs from LIS and how the LIS and middleware interact to coordinate the clinical and operational aspects of the core lab. The webinar will also describe clinical and operational challenges of core lab and how the lab middleware can help solve those challenges.

Speaking on these findings, Jennifer Sanderson, MS, MT, Senior Global Marketing Manager in Digitalization, will help you:

  • Describe the role of middleware in the laboratory
  • List common laboratory challenges that can be solved by middleware
  • Describe how middleware can address clinical and operational challenges in the laboratory

Speaker:
Jennifer Sanderson, MS, MT (ASCP)
Sr. Global Marketing Manager, Digitalization
Siemens Healthineers

Possessing a BS in Health Science, Jennifer earned a Master of Science in Immunobiology from the University of Arizona with an emphasis in Pathogenic Microbiology. With over 20 years of experience serving the laboratory in several roles including technologist and research assistant, Jennifer is now the Sr. Global Marketing Manager in Digitalization. Jennifer supports two key components of the Siemens Healthineers informatics portfolio and collaborates with customers to deliver solutions that bring value to laboratory workflow and efficiency. These solutions support diagnostic laboratories with specific focus on sample, result and quality control management, workflow management and real-time analytics.